Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and Beyond - Episode 4

Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer

Discussion centered around emerging treatment options for patients with HER2+ mCRC, including trastuzumab deruxtucan.

EP. 1: An Introduction to Biomarker Testing in Metastatic Colorectal Cancer
EP. 2: Clinical Trial Review: MOUNTAINEER
EP. 3: MOUNTAINEER-03 Clinical Trial Study Design and Implications
Now Viewing
EP. 4: Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer
EP. 5: The Future of the Metastatic Colorectal Cancer Treatment Landscape